Výsledky vyhledávání - "Garrett E. Bergman"

Akademický článek

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

Autor: Mark A. Matson, Eran Schenker, Michal Stein, Vladislava Zamfirova, Huy-Binh Nguyen, Garrett E. Bergman

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 16, Iss 2, Pp 452-459 (2020)

We conducted a clinical trial to assess the safety and putative efficacy of an additional human rabies immune globulin (HRIG; KEDRAB) versus an older product (Comparator, HyperRAB S/D® [Grifols]) and determine whether HRIG interferes with developmen

Externí odkaz: https://doaj.org/article/63b95ec0e2d24d4d9794f89fbd9c4ace

Zobrazit plný text záznamu

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

Autor: Mark A. Matson, Eran Schenker, Huy-Binh Nguyen, Michal Stein, Garrett E. Bergman, Vladislava Zamfirova

Publikováno v: Human Vaccines & Immunotherapeutics

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f74cc14759614f1ee632524c4e53f8e
https://doi.org/10.1080/21645515.2019.1656967

Zobrazit plný text záznamu

Efficacy, safety, and tolerability of Kedrion 10% IVIG in primary immunodeficiency

Autor: Gordon Sussman, John Hooper, William R. Lumry, Robert D. Pesek, Roberta Macchia, Santhosh Kumar, Ralph Shapiro, Garrett E. Bergman, James N. Moy, Vladislava Zamfirova, Mark R. Stein, Donald L. McNeil, Hartwig Gajek, Julia Upton, Chaim M. Roifman, Agnes Nemet

Publikováno v: LymphoSign Journal. 3:99-109

Background: Primary immunodeficiency involving defective antibody formation requires antibody replacement therapy with immunoglobulin products to prevent and reduce infections. Immunoglobulin for intravenous use (IVIG) is a processed blood product wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ae27f5bb9008233c1e652015fc0cbdf
https://doi.org/10.14785/lymphosign-2016-0004

Zobrazit plný text záznamu

Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A

Autor: Joan Cox Gill, Donald E. Macfarlane, Christine L. Kempton, Philip Kuriakose, W. K. Hoots, Barbara A. Konkle, Thomas C. Abshire, Nigel S. Key, R. A. Deveras, Craig M. Kessler, Garrett E. Bergman

Publikováno v: Haemophilia. 18:798-804

OBI-1 is a recombinant B-domain deleted porcine factor VIII (FVIII). FVIII treatment in those with haemophilia A may be complicated by the development of anti-FVIII antibodies (inhibitors) leading to a failure to respond to treatment with human FVIII

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b6796ffd0763f31cc34f71e9712c943e
https://doi.org/10.1111/j.1365-2516.2012.02789.x

Zobrazit plný text záznamu

The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

Autor: Paula J. Ulsh, Jonathan M. Morris, Garrett E. Bergman, Kristin Kistler, Judith Vensak, David R. Snydman

Publikováno v: Clinical Transplantation. 25:E455-E462

The association between cytomegalovirus immunoglobulin (CMVIG) and long-term clinical outcomes in heart transplantation has not been evaluated using data from large national databases. We examined the association between CMVIG, with and without antiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b3d972db9e0393f9d4acbe792b61cc4
https://doi.org/10.1111/j.1399-0012.2011.01459.x

Zobrazit plný text záznamu

Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)

Autor: Garrett E. Bergman, Christine Joch, Ingo Pragst, Gerhard Dickneite

Publikováno v: Blood Coagulation & Fibrinolysis. 20:535-540

The objective of this study was to characterize the thrombogenicity of one pasteurized fibrinogen concentrate (Haemocomplettan P) in clinical use for over 20 years. Thrombus formation during venous stasis was assessed in rabbits receiving either 100

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3336133c18e9547155b3307547c78b
https://doi.org/10.1097/mbc.0b013e32832da1c5

Zobrazit plný text záznamu

Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures

Autor: Jeanne M. Lusher, Gilbert C. White, Amy D. Shapiro, Hugh C. Kim, Garrett E. Bergman

Publikováno v: Haemophilia. 3:247-253

The present study summarizes results of the efficacy and safety of monoclonal antibody (MAb) purified factor IX concentrate [Mononine® Coagulation Factor IX (Human), Centeon L.L.C., King of Prussia, PA, USA] for surgical prophylaxis in 74 patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebd3126086c4e7aeffb8cf33486c0ac
https://doi.org/10.1046/j.1365-2516.1997.00110.x

Zobrazit plný text záznamu

Safety and Efficacy of Monoclonal Antibody Purified Factor IX Concentrate in Previously Untreated Patients with Hemophilia B

Autor: Marion A. Koerper, Jeanne M. Lusher, Margaret V. Ragni, Margaret M. Hannan, Garrett E. Bergman, Amy D. Shapiro, Steven Culbert

Publikováno v: Thrombosis and Haemostasis. 75:030-035

SummaryThe safety and efficacy of a monoclonal antibody purified factor IX concentrate were evaluated in two continuing trials of 32 previously untreated patients with mild, moderate, or severe hemophilia B. Patients were evaluated every 2 weeks for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ddb3c14c4af2799c26eea50b58f0946c
https://doi.org/10.1055/s-0038-1650217

Zobrazit plný text záznamu

Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand’s disease (VWD) has limited value in dosing for surgery

Autor: William L. Nichols, Jonathan Bernstein, Joan Cox Gill, J. Di Paola, Garrett E. Bergman, Marilyn J. Manco-Johnson, P. M. Mannucci, Stefan Lethagen

Publikováno v: Haemophilia.

Optimal doses of von Willebrand Factor/Factor VIII (VWF/FVIII) concentrates for surgical procedures in patients with VWD need to be determined. A prospective, multicenter study was performed that included an initial pharmacokinetic (PK) assessment fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e37650c2b0a688030189de8da0a5848e
https://doi.org/10.1111/j.1365-2516.2011.02583.x

Zobrazit plný text záznamu

The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

Autor: David R, Snydman, Kristin D, Kistler, Paula, Ulsh, Garrett E, Bergman, Judith, Vensak, Jonathan, Morris

Publikováno v: Clinical transplantation. 25(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::83c8b93b0316fd43ec9d5da551610847
https://pubmed.ncbi.nlm.nih.gov/21504474

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání